LMR Partners LLP

Position in TNGX — Tango Therapeutics, Inc.

CIK 1578621 LONDON, X0

Position in TNGX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$10,850,533

+$10,730,413 QoQ

Shares Held

347,106

+2379.3% QoQ

Ownership

0.206%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

#72

of 245 holders

Holding Since

Dec 2021

12 quarters on record

Voting authority Sole 99% Shared 1% None 0%

Healthcare · as of Jun 30, 2026

LMR Partners LLP holds $188,480,644 across 75 Biotechnology names. TNGX ranks #4 (5.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	134,214	$40,402,439
2	DNTH	Dianthus Therapeutics, Inc. /DE/	223,995	$21,835,032
3	REGN	Regeneron Pharmaceuticals, Inc.	22,306	$13,908,683
4	TNGX	Tango Therapeutics, Inc. This page	347,106	$10,850,533
5	RVMD	Revolution Medicines, Inc.	5,112,098	$8,521,240
6	ARGX	Argenx SE	8,200	$7,607,714
7	DFTX	Definium Therapeutics, Inc.	150,200	$7,065,408
8	NKTR	Nektar Therapeutics	100,000	$6,981,000

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,850,533	347,106	+2379.3%	Shares	Other	2026-08-14
2024-06-30	$120,120	14,000	0.0%	Shares	Other	2024-08-14
2024-03-31	$111,160	14,000	0.0%	Shares	Sole	2024-05-15
2023-12-31	$138,600	14,000	-44.0%	Shares	Sole	2024-02-14
2023-09-30	$281,500	25,000	0.0%	Shares	Sole	2023-11-14
2023-06-30	$83,000	25,000	0.0%	Shares	Sole	2023-08-14
2023-03-31	$98,750	25,000	0.0%	Shares	Sole	2023-05-15
2022-12-31	$181,250	25,000	+49.9%	Shares	Sole	2023-02-14
2022-09-30	$60,363	16,675	0.0%	Shares	Sole	2022-11-14
2022-06-30	$75,537	16,675	-33.3%	Shares	Sole	2022-08-15
2022-03-31	$189,500	25,000	-35.0%	Shares	Sole	2022-05-16
2021-12-31	$420,741	38,459	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.